Santé Canada approuve DOPTELET (avatrombopag) pour deux indications en thrombocytopénie WALTHAM, Mass., 08 nov. 2023 (GLOBE NEWSWIRE) -- Sobi Amérique du Nord, la filiale nord-américaine de Swedish Orphan Biovitrum AB (SobiMD), a annoncé aujourd’hui l’approbation par Santé Canada de...

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

Annals of Rheumatic Diseases Publishes Results from Phase 2 Study of emapalumab in Patients with Secondary HLH/Macrophage Activation Syndrome WALTHAM, Mass., April 04, 2023 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®) (STO:SOBI), today announced that the Annals of Rheumatic...